m-

h* * ** mg a @ _%%TMMM agg3373Lgn

Q PAGE ) 6 !|4 NRC FORM 374.- O F PAGES

1 0 0-89) U.S. NUCLE AR REGULATORY COMMISSION

)!MATERIALS LICENSE Amendment No. 254

1|q Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10, {hp,

q Code of Federal Regulations, Chapter 1, Parts 30,31,32, 33,34,35,39,40 and 70, and m reliance on statements and representations heretofore |!p

% made by the licensee, a license is hereby iwued authorizing the licensee to receive, acquire, possess, and transfer byproduct, source, and special N'

h nuclear material designated below; to use such material for the purposets) and at the placets) designated below, to dehver or transfer such material %'

to persons authorized to recene it in accordance with the regulations of the applicable Part(s). This license shall be deemed to contam the conditions

j ] specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is subject to all applicable rules, regulations and orders of the Nudear pj Regulatory Commission now or hereafter in effect and to any conditions specified below. yf f? beensee f1 In accordance with the letter dated Jl January 27, 1994, I

f 1 George Washington University 3. Ucense number 08-00216-22 is amended in hJ its entirety to read as follows:|D

j 1 2300 Eye Street, N.W., Room B-32 | I] Washington, D.C. 20037 4. Expiration date September 30, 1989 (Extended) |k

,

k ',

5. Docket or gi4,

d Reference No 030-09049 g6. Byproduct, source, and/or 7. Chemical and/or physical 6. Maximum amount that licensee |li

%~ $1

special nuclear material form may possess at any one time |E9405130059 940331 under this license I

y|ijPDR ADOCK 03009049C PDR. - f>~,

h[ A. Any byproduct material with ' A. :Any U A. See Condition 12 [

Atomic Numbers 1-83~ 'c() ''t i~ %

dB. Cesium 137 c'f B.iSealed sources '(3M Model B. 1s ,urie |,;.

c p:

y -2606C). 2 .m. jE ~~3 &

h C. Cesium 137' C.' Sealed source-(Nuclear , ' C.100, millicuries >:

,

A3 - ' Associates Model ,64-764) ' s.

D. Hydrogen 3 T D. Any= > ( ' ' i ! +; ' D.15fcuries j;9 E

.'

,

. Iodine 125 rN : E. Sealed sources 1 E. 1, curie p'

D F. Iodine 125 '. - 'F.1 Anym -M F."2 curies 'i0 G. Iodine 131 W G.' Any + i' G.,2 curies k:

i H. Iridium 192 H. Metallic Platinum % H.d2 curies k,

IridiumLWire in Ny bn (%' f~

:

Ribbon v.7 (11. Molybdenum 99 I. Any N I. 10 curies l|y,

^ 1 .,I J. 3 curies| J. Phosphorus 32 J.7Any.

: K. Strontium 90 K. Sealed source (3M Model K. 50 millicuries y ,

6DIA) :13

L. Technetium 99m L. Any L. 10 curies 7:

N.Nottoexceed1.5 curies (,jM. 4 curiesM. Xenon 133 H. Any:

: N. Gadolinium 153 N. Sealed source !per source p,

? 0. Uranium (Depleted in 0. Cadmium plated metal 0. 300 kg. tUranium 235) h

FP. Thorium 228 P. Plated source (Isotope P. 1 microcurie(:'Products Model AF-200)

1Q. Thorium 230 Q. Plated source (Isotope Q. I microcurie I,1 Products Model AF-200) !jj R. Plutonium 239 R. Sealed source (Mound R. 5 curies p |

~

Laboratories Model fl'

..

U, .-- NUMEC-N) il-

S. Plated source (isotope S. I microcurie j |^

S. Americium 241 Lv- u

Products Model AF-200) g |T. Curium 244 T. Plated source (Istope T. 30 millicuries y

t[ OFFK;tAL RECOf4D COPY Products Model XfB-3) tL 10 j_ , , . - - - _ _ _ - . . - - - - -

|

*

? .

,

C o| 4 ** '

License number |i 08-00216-22 i( MATERIALS LICENSE Et>ocket or Reference number '

( SUPPLEMENTARY SHEET 030-09049 >1i 4 P iI (

|p'

q Amendment No. 25 y !

9. Authorized use |i

'

n

A. through N. Medical research, diagnosis, and therapy; research and development as j'

defined in 10 CFR 30.4; animal studies. ! '

| 0. For use as shielding.| !

P. through T. Research and development as defined in 10 CFR 30.4.,

I '

CONDITIONS 4

| |'

10. Licensed material shall be used only at the licensee's facilities bounded by |Pennsylvania Avenue, 24th Street N.W;, 19thiStreet, N.W., E Street, N.W., and New i|

Hampshire Avenue, N.W., Washington 10.C., with~a' central address of 2121 Eye Street, '

N.W., Washington, D.C.g

11. A. Licensed material shall be used by, or under the suhrvision of, individuals;

l designated by the George Washington University Radiati*on Safety Committee, f'| Alan G. Wasserman, M.D., Chairman. |-1 ,. e v .. 4

'.~.

| B. The use of licensed materialxin or on humans shill be by 'a physician as definedyI in Section 35.2 of 10 CFRtPart 35 A- . C)(' &';T-4 4by) ?

Physicians designated to. use licensed-[ material in or on humans shall meet the2 mC.

training criteria establishe'ddn~Appendli4ofiRegulatoryiGuide 10.8(Revision 1),tdatedOctoberfl980p|and-asar#esised December-2, 1985 (47 FR 54376), pp

~y , % ,1 JiN m' & ,1{""

; -

! D.Radiation Safety Officdr:, , Tebrry A.! D hnison, C.H.P.

* '

In addition to the possession limits. in Item 8T, thi license $ ||lf.s 4ki 11 LUhk ?12. e shall limit the amount

of material possessed to the quantity specified infl0 CFR,30~.35(d) for establishing |p1$150,000 as the required: amount of financial assurance for' decommissioning. '

',f13. In addition to the possession limits in Item 8, the licensee shall further restrict fthe possession of licensed mate'r'ial...at a single location to quantities below the3

Q|| limits specified in 10 CFR 30.72 which require cdnsideration of the need for an

emergency plan for responding to a release of licensed material.

14. The licensee shall not acquire licensed material in a sealed source or device unlessi !

the source or device has been registered with the U.S. Nuclear Regulatory Commission @Ai ! pursuant to 10 CFR 32.210 or equivalent regulations of an Agreement State.h

p%15. 4,

A. Sealed sources and detector cells shall be tested for leakage and/or |N<i contamination at intervals not to exceed 6 months or at such other intervals as A'! are specified by the certificate of registration referred to in 10 CFR 32.210, !?,''

I not to exceed 3 years. g

{hi -

%

>>N,

_ _ _ _ . _ _ j _

|_. . .

- .

, ym. 7- r--wmarmsarmur==wnerrmwm ressmu---e wamanemssmastmewamqpace 3 or 6 paces Mq NRC Form 374A U.S. NL .R REGULATORY COMMitStON l

el P"I License number h

MATERIALS LICENSE Docket or Reference number

fSUPPLEMENTARY SHEET

030-090494 Fi Amendment No. 25 F

4 k i

(j (15. Continued) CONDITIONS'

;

| B. Notwithstanding Paragraph A of this Condition, sealed sources designed to emit f 1

q alpha particles shall be tested for leakage and/or contamination at intervals t |

u not to exceed 3 months. E

i li C. In the absence of a certificate from a transferor indicating that a test has I| been made within six months prior to the transfer, a sealed source or detector f

- |,

i cell received from another person shall not be put into use until tested. y.

|| F :

Each sealed source fabricated thRlfceit'see shall be inspected and tested for iconstruction defects, leakagW,bh'and confaininitrion prior to any use or transfer as

1 D.$ i

1

{ff| a sealed source. Gv ~

''- ;1

Sealed sources a<nd etector cells need not be leak tejted if:E.x, t3.

(i) they contain ohly hydrogen 3; or f/ r, (;Ij# %" y A

;

(ii) theyconbnonlya_[y| |;

or ~gn (- g_ p> e- g

-ope is 30 day orjless; orO r

xg (iii) the half 41ife of tl}e n

'R n100micr},o f/ beta an" jor gamma emitting isw A g~>

4 ,

! (iv) theycoht'aingo' ' ore Jpgs'

Wrin|iff ur,}(<eirofj .*pha em' ting material; orl Ij materialfor n 're"t-j x R- u

| (v) they are(St dek 't qi i h g rti E,'are'astorage,andarenot |, ,

i

Howe,_h; son > dan$e regrf,pm from s)orage for use or p4 being use%,

noth'er perave n /before w)st or transfer.een tep pd within the required

hi transfer t

source or del,e val, the) s'h'allii 'p, pct'est No sealed E! leak test tr cell shall./belstored for a r'iod of more than 10 years k

spd for leakage and/or con $g@nfiation. |' e

| without being4 s4 v b

5 F. The test shall be capable ef detecyog,the presence of 0.005 microcurie of p

radioactive material on the test samplef' Records of leak test results shall be>|

.

> jkept in units of microcuries and shall be maintained for inspection by thehCommission. If the test reveals the presence of 0.005 microcurie or more of'

'

, q removable contamination, a report shall be filed with the U.S. Nuclear h !

J W Regulatory Commission and the source shall be removed from service and I?j decontaminated, repaired, or disposed of in accordance with Commission plm regulations. The report shall be filed within 5 days of the date the leak test F|j result is known with the U.S. Nuclear Regulatory Commission, Region I, ATTN: p

Chief, Nuclear Materials Safety Branch, 475 Allendale Road, King of Prussia, yqq Pennsylvania 19406. The report shall specify the source involved, the test g( results, and corrective action taken. pj|| pl

i

,

s b

k kH |sd

k'L4 g,fW p

4 Wi K$ $

masszasamasasswwmammwzacaczsax2srac32WGMis1&DDeh. . _ . - .- - .- .

-.

gt%warwanrXE% renc Form 374 A U.S. NU H REGULATORY COMMIESION 4 6p cr pncrs

A License number '

08-00216-22M ATERIALS LICENSE

k SUPPLEMENTARY SHEET |*" *' # "#' ""

I 030-09049 |4k i

Amendment No. 25

f (15. Continued) CONDITIONS l

G. The licensee is authorized to collect leak test samples for analysis by theQ licensee. Alternatively, tests for leakage and/or contamination may be l# performed by persons specifically licensed by the Commission or an Agreementf State to perform such services.

16. In lieu of using the conventional radiation caution colors (magenta or purplt. onyellow background) as provided in Section 20.203(a)(1), of 10 CFR Part 20, the

q( licensee is hereby authorized to label detector cells and cell baths, containing.

|

,licensed material and used in gasrchromatography devices, with conspicuously etched4

or stamped radiation caution symb~ols without a solor requirement. i

17. Detector cells containing scandium tritide foil shall only be used in conjunction lwith a properly operating temperature control mechanism which prevents foil '

temperatures from exceeding 325 degrees Centigrade.$d 18. Radioactive gases as-free gascor in solution to be administered to humans shall be ;

| procured from a supplier which| distributes the product indicated for human use inIaccordance with the Federal Food; Drug, and Cosmetic Act.

H 19. The licensee may use the Lineator, device for doing linearity tests of its dosecalibrator provided it follows;the p' ocedures_ingthe Atomic Products Corporations rLineator Instructions Manual datedNune ;20 '1983. -jf.I,3 * l

20. Needles or standard medical?applicatortcells containing cobalt-60 as wire shall not j :

|%. be opened by the licensee. i % 4,

:4 ..

.

,

d 21. Patients containing cobalt-60, cesium-137 or iridium-192 ird ats shall remain |

q hospitalized until a source count and4urveys made with(an a;a ariate radiationj detection instrument indi'cate that all implants have been r r .'*. The results ofk these surveys shall be recorded and maintained for inspectic , by '.he Commission for 5

years from the time the implants areiremoved.|

L 22. Patients containing Iodine-131 for the treatment of thyroid carcinoma (or patientst containing therapeutic quantities of Gold 198) shall remain hospitalized until theh residual activity is 30 millicuries or less. ,

23. The licensee shall conduct a physical inventory every 6 months to account for all@ sources and/or devices received and possessed under the license. Records of

inventories shall be maintained for 2 years from the date of each inventory.

<df Ai

$ |1

<

!

L !

hu - ~=~ ~ > ~ : - - _ , ,,w n _ ,)

. . .

. .

, gammmmmmarzwarmrsramra .. - m .mmansemwzwansrawarsgq NRC Form 374A U.S. NL .R REGULATORY COMMifSION 5 6 p,,oc y ,,cos

4 F License number k

! MATERIALS LICENSE-

h'' " ' ' " ' * " "

|SUPPLEMENTARY SHEET 030-09049

4-

: s Amendment No. 25y4

| (Continued) CONDITIONS

| 24. Sealed sources or detector cells containing licensed material shall not be opened ore sources removed from detector cells by the licensee. S ,

8 N1 25. The licensee may transport licensed material in accordance with the provisions of bj

3

10 CFR Part 71, " Packaging and Transportation of Radioactive Material".

g 26. The licensee is authorized to hold radioactive material with a physical half-life of (j q 1ess than 90 days for decay-in-storage before disposal in ordinary trash provided: p.

!1 eMN [- D E"1 4 A. Radioactive waste to be disposed of'in"this manner shall be held for decay a E

j |minimum of 10 half-lives. d,

||B. Before disposal as normal waste, radioactive waste $ hall be surveyed to [|

|

q ' determine that its' radioactivity cannot be distinguished from background. All p

it radiation labels,shall be removed or obliterated. sq'

r,

kjfi J c_ o-Generator colu;mns shall be, segregated so thatithey may be monitored separately h) Ii C.

; f to ensure decay to background level,s'~ prior to disposal. [; ;

n . . , f i s;.

D. Radioactive waste estimated:to containiless than 5 microcuries of byproduct pip

j Jmaterial with a physical half-life from i60: to 90_ days may;be disposed to the p:

#[: ;

ordinary trashiafterLbeing' held [tes> iniist 'be monitored invabcordance with theforfdecay!for'a minimum of ^five (5) half-lives.E' !

Prior to the ~ disposal,: these was h!: ;: i proceduresdescribedin'thelicehse~eTsia'bplication'datedTMay 17, 1984, as 4

[;3 amendedbyletterwithenclosure's|dalbd4 September 17, 1984. The survey! i conducted prior'to disposalimust' confirm that :the radiofactivity of the wastes p

( cannot be distinguished from' background. ? Fi>< 1 p 3; y

i | 27. Experimental animals administered licensed materials o"r[their products shall not be F

| j used for human consumption."

| J

| 28. Pursuant to Section 20.105(a) of 10 CFR 9 Art 20, and in reliance on statements, h^

i

procedures and representations made by the licensee in his letter dated August 12, F,

1986, the following maximum radiation leveis are hereby authorized in the following h4

y; y unrestricted areas: [

Maximum Radiation Level Unrestricted Area |Nj 250 millirems in any seven Eighteen (18) inches from #

consecutive days walls in hallways and patient rooms adjacent K,y to rooms occupied by patients undergoing k.

EM radionuclide therapy or brachytherapy.$ h1 8-

4.

Y'

G=- - _ _ _ _n-- _ -

_ _ __ _ _ _.

___

p'mwnrumrrsrswauwahamr4u.s. nuh=R REGUt.MORY COMMISSIONQ ggg 6 6 I

c =u nsrannannerrrawrawmarriwems :

( wnc rorm ana or mac s ~l4 License nutnter

0 MMMATERIALS LICENSEg ,, k, , ,, g ,,,,, ,,, ,, rn t

SUPPLEMENTARY SHEET I'

030-09049

4

( Amendment No. 254

(Continued) CONDITIONS

29. Except as specifically provided otherwise in this license, the licensee shall conduct4 its program in accordance with the statements, representations, and proceduresN contained in the documents including any enclosures, listed below. The Nucleari Regulatory Commission's regulations shall govern unless the statements, ,

j representations and procedures in the licensee's application and correspondence are '

j more restrictive than the regulations.!e A. Application dated May 17, 1984

. .

I B. Letter dated September 17, .1984 -including' ALARA Program4 C. Letter dated November 14,T1985

| D. Letter dated January >7, 1986q E. Letter dated April,7,"1986 h( F. Letter dated August-12, 19864 G. Letter dated October 7, 1986$ H. Letter dated September 13, 1988

i|I. Letter dated Ariril 28, 1989 -

J. Letter dated July 7, 1989hq K. Letter datedf0ctober 31,-1990

g,,j( L. Letter datedrEebruary 5, 1991q M. Letter dated March 13, 19914i N. Letter dated-May 8, 1991 a

~

m

| 0. Letter dated' January 27, 1994 g-

{N>

nk

i 93

| |

4 | j

d |r.' l

| EF

q

4

56

9

4' .

t

441

4 For the U.S. Nuclear Regulatory Commission

| Original Slgned By: .

M h med M. ShanbakyDate By

Nuclear Materials Safety. Branch .

A Region I ,

| King of Prussia, Pennsylvania 19406 !

AwCMammmw3Naauwamrammmeassmsreamememmamamgixmgwsgcan$1

y 3, .

. ,

NOTE TO DMB:

TIIE A'ITACIIED DOCUMENTS ARE TO BE PROCESSED AS QNE MATERIAIELICENSING PACKAGE.

LICENSE NUMBER; #I ' 8d 2 /4 -d 2

DOCKET NUMBER: d 3 8- 6fd#[ECONTROL NUMBER: //d [$7

TIIIS SIIEET MAY BE DISCARDED AFTER PROCESSING.

TIIANK YOU!

!

I

{-

1-

1-

1

i

i

-. .

O O-,

G 3 | !a2a

License Number: 08-00216-22Docket Number: 30-09049Control Number: 116551

George Washington UniversityATIN: Allan G. Wasserman, M.D.

Chainnan, Radiation Safety Committee2300 Eye Street, N.W., Room B-32Washington, DC, 20037

Dear Dr. Wassennan:

Subject: Financial Assurance

This is in reference to your submittals dated July 26,1990, November 2,1993, January 27,1994 and February 11,1994 to amend your possession limits and your submittals dated July26.1990, September 6,1990, March 18,1991 and April 16,1991 with attached Letter ofCredit and Standby Trust Agreement to establish financial assurance for NRC License No.08-00216-22. We have reviewed your submittals and within the scope of our review, nofunher deficiencies were identified.

Based on our review of your submittals and concurrent with the issuance of Amendment 25of the above mentioned license, you are now in compliance with the requirements of 10 CFR30.35. Please note that financial assurance certification and all associated documentation are |required to be updated with significant changes in your operation and with each applicationfor license renewal.

1

If you have any further questions regarding this letter, please contact David Everhan at j

(610) 337-6936. Thank you for your cooperation in this matter. 1

Sincerely,

Original signed By:Moharned M. Shanbaky ;

Mohamed M. Shanbaky, ChiefResearch and Development SectionDivision of Radiation Safety

and SafeguardsEnclosure:Amendment No. 25

OFFICIAL RECORD COPY - C:\ DOC \DECOMM\GWU - 03/25/94 ,

|i

. 's.EN *

|-

.

) !O ('J,

|O ~.

1

l

1

George Washington University -2-

bec:M. Shanbaky, RI ;

D. Everhart, RI 1

|

|

|

l

:

,

|

0)DRSS: -/ - DRSS:RIEverha Shant-ky

3d/94 3 /94

OFFICIAL RECORD COPY - C:\ DOC \DECOMM\GWU - 03/25/94

i

TED 11 '94 07:39 PM ( ATION SAFETY GWU 202 994 * Po9e 1

The,

1 -COr ekSSal LOnUnive ity

WA % HING T ON DC

MEDICAL ONTER

RADIATION 5ATETY Os rict

FAX'IRANSMITTAL COVER MEMORANDUM

Fm. 6. //, /r 7fFAX NO: (202) 728-4056 DA'E:

Dee ero L,fDeliver to: z

u 1 AIR C Reu.1 1' J i,

!

d / O' M7- $3 D Telephone No: IFax No:

. Sent By: 'kTFV .hnCD5| c m .'' w a a % % w v| J

We are sending _ b pages including this cover sheet.

Additional Message: Ili coa bkW CArLOP Oa/tMi/

d ou e c L r G G I J h rbi e u to t o h |R M . iJ l

?leue : a ,+ al/ price h- w ~ m tc.' /

G DO N cia k a S VotO~ N|n In h; j

Le m s c e. h OhGfvei( WC' f,

/ / /

Please confirm the receipt of these pages. Yes X No

Call: Oftwimdl 7 rr v 6o 4 A eo 4 at: 202-994-2630/

RSO (10HS)OFFCIAL RECORD COW EW

/|(, f5'l2300 EYE STRETT, N.W. * ROOM B42 * WAS!!! melon, DC 2003? * UOJ)W4 2030 .fj|g

FAX RECS -

_ . . _ . . _ .

. _ _ _ _ _ _ _ _ _ _ _ _ _ _ _

i]rtce ti s4 07:ss es ATion sarciv owu 282 984 eos. 2

Items 5 and 6. Radioactive material to be possessed, and purposes for which it will be used.

Item 5. a. Isotope (s) b, Chemicaland/or c. MaximmnPhysical Form * Amoimt

A. Any byproduct materials Any fonn 3 curies per isotope;with atomic numbers 1 through 83, 30 curies combinedwith half life less than 120 days totalof allisotopes

B. Mo-99 and/or Tc-99m Any fonn 10 curies

C. Any byproduct materials Any form 0.03 curie per isotope;with atomic numbers 84 through 103, 0.05 curie combinedwith half life less than 120 days total of allisotopes

D. Any byproduct materials Any form See Condition 12with half life greater than 120 days

E. Any byproduct materials Scaled sources, 2 curies per isotope;with atomic numbers 1 through 83, plated soumes, and 10 curies combinedexchiding I-129 and alpha emitters platinum-iridium wire totalof allisotopes

F. Any byproduct materials (e.g., I-129, Scaled sources, and 0.5 curie perisotope;Po-210, Am-241, Cr.1-244, & Cf-252) plated soumes 1 curie combined

total of allisotopes

G. Plutonium (mixed Pu isotopes) Sealed source (Mound 5 curiesLaboratories ModelNUMEC-N)

H. Any source materials Any form 0.01 cuiie combinedtotal of allisotopes

I. Uranium, depleted in U-235 Metal 300 kg

*All sealed sources shall be registered pursuant to 10 CFR 32.210, or registered in an Agreement State.

Item 6. A. through H.: Research and development as defined in 10 CFR 30.4, studentmstructmn, calibration, instrument checking, quality assurance,image marking, p iysical and chemical analysis, and animal studies;

,

these uses do not nelude the internal or extemal administration ofradioactive material or radiation to human beings (except small ganunasoumes used to mark images produced as authorized by this license).

Also, medical diagnosis, therapy and research in humans in accordancewith any applicable Food and Drug Administration (FDA) requirements.

I. Counterweighting and/or radiation collimation or shielding.

Condition 12: If only one radionuclide with a half life greater than 120 days is possessed, thepossession limit is 10,000 times the quantity specified for that radionuclide inAppendix C to 10 CFR 20. If two or more radionuclides with halflives greaterthan 120 days are possessed, the possession limit is detennined as follows:For each radionuclide, determine the ratio of the quantity of unsealed byproductmaterial possessed to 10,000 times the applicable quantity specified in Appendix Cto 10 CFR 20, for that radionuclide. The sum of the ratios for all radionuclides withhalf lives greater than 120 days possessed under the license shall not exceed unity.

_ _ _ - _ _ - _ _ - _ _ _ _ _ _ _ _

_ - _ .-

~

-

O The O ms-/6-

1

eorge x-z-

1 asalh ton'

.

Unive ity iWASHINGTON DC

h1EDICAL CENTER l

R ADi4 rlON 5 All TT ()fl'H1

January 27,1994

U.S. Nuclear Regulatory CommissionRegion I475 Allendale RoadKing of Prussia, Pennsylvania 19406 |

|

Attn: Dave Everhart |

Dear Dave:

Pursuant to your letter of December 28,1993, please approve the attached restatement of thepossession limits of our current broad scope license, and of the renewal application affecting thatlicense. This new restatement of our isotope possessions and uses is intended to replace Items 6,7,8, and 9 of our current license amendment, dated June 24,1991; and is intended to replace Items 5and 6 of our most recent license renewal application, dated November 2,1993.

With the line-by-line possession limits as now stated, it is virtually impossible to exceed thelimitation on all isotopes combined that is imposed by 10 CFR 30.72, Schedule C, given only thatthe possessions for Nuclear Medicine and Radiation Oncology --Items A through D - subsume,

only about 5% of that limitation, as they do in fact, even though the possession is stated "asneeded." '

4

The last paragraph of the new restatement ties down our compliance with 10 CFR 30.35, with "R"value limitations covering the entire broad license, i.e., the line items for medical use as well as theresearch line items, and covering each individual isotope (R 5 3,000) as well as the combined total(R s 10,000). The method of ensuring compliance is also clearly stated, and is very conservative,using inventory of all user authorizations approved by the Radiation Safety Committee (actualpossession is of course much less).

I hope this version sails through the approval process quickly. If any particular line item causes aproblem, please alert me by telephone right away so that we can correct it.

If you have any questions or concerns, please call me at 202-994-3149.

Sincerely,

@~Terry JohnsonRadiation Safety Officer

, ,, ,

TJ/gjh (10Illb94 toritr) C-M N q.M

c nCIAL. RE@BD MW ML 10 I G/Uno &E STRE FT. NW. . Roost 1562 . huiNOToN. DC 2oor . uomr+20m

_ ._ .

_ _ _ _ _ _ _ _ _ _ _ _ _ _

-.

, ,.

NRC .8 0f' M 313U S. NUCLEAR REGULATOAY COMMISSION

, ga g APP %OVEDSV OMB-C CFR 30 3184 012024 :s e* E" 33 APPLICATION FOR MATERIAL LICENSE E Pm no io.

( )NSTRUCTIONS. SEE THE APPPCPRI ATE LICENSE APPLICATION GUIDE FOR DET AILED INSTRUCTIONS FOR COMPLETING APPLICAil0N SEND TWO COPIES' '0F THE E NTI AE COMPL ETED APPLICATION TO THE NRC OFFICE $PECIFIED BE LOW

APPLICATIONS FOR DISTRieUTION OF EXEMPT PRODUCTS FILE APPUCATIONS WITH IF YOU ARE LOC ATED IN

U S NUCLE AR RE GUL A TORY COMMISSION IL LINOIS INDI AN A,10n A MICHid AN. MINNESOT A. M1850URI. OHIO, ORDe OSiCN OF INDUSTRI AL AND MEDIC AL NUCLE AR SAFETY, NMS$ WISCONSIN, SEND APPLICATIONS TOW ASHsNGTON OC TJ555

U $ NUCLE AR REGULATORY COMMISSION. AtGION iltALL OTHER PERSONS FILE APPLICATIONS AS FOLLOWS. IF YOU ARE M ATE Rf ALS LICENSING SECTIONLOCATED IN 799 AOOSEvf LT RO AD

GLEN ELLYN. IL 60137CONNECTICUT. DELAW ARE. DISTRICT OF COLUMSIA M AINE. M ARYLANDM ASSACHUSETTS NEW H AMPSHIRE NEW JE RSEV NEW YORK, PENNSYLVANI A. ARK ANSAS COLORADO,10AHO. K ANSAS LOultl ANA. MONT ANA. NEBRASK A.

RHODE ISLAND. OR VERMONT. SENgAPPLICATIONS TO NEW MExlCO. NORTH DAKOT A. OK LAHOMA, SOUTH DAKOT A. T EXAS UTAM,

U S NUCLE Aa nEGULATORY COMM:S$10N REG +CN INUCiE AR M ATER'ALS SAFETY SECTION B U S NUCLE AR REGULATORY COMMISSION REGION IV4'S Au END ALE ROAC M ATERI AL R ADI ATION PROTECTION SECTIONMrNS OF PRUSSI A. P A ,19M 611 R Y AN PLAZA DRIVE. SUITE 1000

ALAB AM A. FLORID A. GE OROI A. K E NTUCKY MISSISStPPI. NORTH CAROUNAPUERTO RICO. SOUTH CAROLIN A. TENNESSEE. VIRGINIA. VIRGlN ISLANDS. OR AL ASK A ARI2ONA CALIFORNI A, MAwall. NEVADA OREOON. W ASHINGTONWEST VIRGINIA. SEND APPUCATIONS TO AND U.S.' TERRITORIES AND POSSES $10NS IN THE PACIFIC, SEND APPLICATIONS

TOV $ NUCLEAR REGULATORY COMMISSION REGION 11NUCEAR MATERIALS SAFETY SECTlGN U S. NUCLEAR REGULATORY COMM!$$10N REGION V101 M ARIETTA STREET, SULTE 29u0 NUCLEAR MATERIALS SAFETY SECTIONATLANTA. GA 3C323 1450 MARIA LANE. SulTE 210

WALNUT CFtEEK, CA 94696

PE RSONS LOCATED IN AGREEMENT ST ATES SEND APPLICATIONS TO THE U S. NUCLE AR REGULATORY COMMISSION ONLY 1F THEY WISH TO POSSESS AND USE LICENSED MATERI ALIN STATES SUBJECT TO U S. NUCLE AR REGULATORY COMMISSION JuniSOiCTION.

1 THIS IS AN APPLICATION FOR (Chece approar are treme 2 N AME AND M AILING ADDRESS OF APPLICANT (seveele Coae>~~

The George Washington UniversityA NEW UCENSE

T s AMENDuENT tO UCENSE NLMSER OR-on?t6-?? Office of ResearchC RENE* AL OS UCENSE NUMBEa 2300 I Street, NW, Suite 708

~

Washington, DC 20037J ACORE SSiE S)AwEaE UCENSE D M A'ER > A W'LL BE USE D C A PCSSESSIC

/e\U<>

4 N AVE QF PERSON TC S E CON T AC TE D AB OUT Tm1 AP8LCA T ON TE LEPHONE NUM6ER|

Terry A. Johnson 202-994-2630SLBYif ITEYS 5 THROwGd 11 ON 9 , a 11 P APE R tsE TvrE ANO SCOPE 08 INFORM ATION TO BE PROviDED 15 DESCRISED IN THE LICENSE APPLICATION GUIDE

5 R AOlC ACTWE M ATEa ALa E .e+ eat eac mais veer t) c ema. and o cavi<alow aad i: ma a mom amw 6 PURPOSEtSI FOR WHICH LICENSED M ATE RI AL WILL SE USEOa

nr .caem oe poneued et a v one we

g TnatNtNG FOR tNDIVIOU ALS WORKING IN OR FREQUENTING RESTRICTED ARE ASRA N A e E

9 8 ACtUT ES AND E%. PVEU to R AOi Af rON S A88T F PROGRAM

12 VCE%SEE * E ES4500 00CF R I/U emt Sectron f /0 3 0)'s A ASTE M AN AGEMEN" l' MOUNT

,

|FEE CATEGORY 7B | E NCLOSE D s 500.0013 CE a Ti8 { A tiCN rMar the como s'ad in soor< ant! THE APPUC ANT VNDE RST ANOS THAT Au, ST ATEVENTS AND RE PR SENT ATtQNS M ADE IN TMil APPLlCATION AR E

8'NO:N's PON T=E AP*L CA U

TME ADei.C ANT ANO ANY C 5 5'CI A L EX ECLTiNG t+$ CE R T'8 tC ATION ON B E w AL8 Os THE APPUC ANT. N AvtO IN ITEM 2. CERTIFY TM AT THIS APPUCATION ISPR E p AR E D rN CON 8 0 AM Tv mT W TIT.E 10 CCOE 0 8 S E O E R A. n E GU L ATIONS. P ARTS 30 32. 33. 34 35 ANO 40 ANO TM AT Au. sNFORMATION CONT AINED MEREiN15 TavE Av CORREC' TO THE BEST 08 THEIR KNOWLEOGE AND 8EL.E6WanNiN d S C S E C90N '00' A CT O F JU N E 25 '948 62 ST AT 749 MAu ES iT A CRIMIN AL C88 ENSE TO MAK E A WILLFULL Y F ALSE STATEMENT OR REPaESENT ATf 0NTO AN f OEF AttiviNT OR AGENCY'C8 THE VNtTED ST ATES AS TO ANY M ATTE R W!TMsN ITS JURISDICTION

S.G N ATL RE-CERT:F * N ) 08 FIC58 TvPEO Pa+NTED N AME TITLE DATE-

{ / M' p'} g', pj,m Roger E Meyer, M.D. Vice President for Medical j

Affairs and Executive Dean#

O t. 1; y v-

FOR NRC USE ONLV' w P6 QE FEE FEE LOG g 8 E E C A T E .iC a ' COYVENTS

SMO R % 2.6.

AMm? _E O _ .-

@ k,g .d,4

AP* ROVE D B Y # l' DATE

&yN A C E O'R V } ? ) g40 EST.M ATE O llL* C E N PE R R E SPCNSE * O COMPLY wit * THis iN80RM ATION COLLECTION PEQUEST 7.5 HR S

FORW ARO COMMENTS R EGARDING BVRCEN ESTIM ATE TO THE RECOROS AND PEPORTS MANAGEMENT BR ANCH iP.6301. U S NUCL E ARREGvL ATOP Y COMWSSION W ASHINGTON DC 208iS5 AND TO THE OFFICE OF INFORM ATION ANO REGULATORY AF F AIRS. OF FICE OFMANAGEVENT AND BUCGET. W ASHINGTON DC 20503.

| -.

|' O Oitems 5 and 6. Radioactive material to be possessed, and purposes for which it will be used.

Item 5. Part I. Medical Use, and Incidental Uses,

a. Isotope (s) b. Chemicaland/or c. MaximumPhysical Form Amount

A. All byproduct materials All fonns usable As neededidentiTied in 10 CFR 35.100 under 10 CFR 35.100

B. All bypeduct materials All forms usable As neededidentified in 10 CFR 35.200 under 10 CFR 35.200

C. All byproduct materials All fonns usable As neededidentified in 10 CFR 35.300 under 10 CFR 35.300

; D. All byproduct materials All fomis usable 3 curiesj identified in 10 CFR 35.400 under 10 CFR 35.400 in total

E. All byproduct materials All sealed sources usable 3 curiesidentified in 10 CFR 35.500 under 10 CFR 35.500 in total

|| F. Any byproduct materials, but Scaled, plated or 0.3 curieI excluding I-129 and alpha emitters plastic sources, floods, in total

and calibration standards

G. Any bypmduct material Any form 0.03 curiein total

H. Uranium, depleted in U-235 Cadmium-plated metal 300 kg

I. Reserved

item 6. Part I. Medical Use, and Incidental Uses.

A. All uptake, dilution or excretion procedures approved in 10 CFR 35.100.

B. All imaging or localization procedures approved in 10 CFR 35.200.

C. All radiopharmaceutical therapy procedures approved in 10 CFR 35.300.

D. All brachytherapy procedures approved in 10 CFR 35.400.

E. Medical use of sealed sources included in 10 CFR 35.500,in compatible devicesregistered pursuant to 10 CFR 30.32(g).'

F. & G. Calibration, quality assurance, image marking, instrument checking, studentinstruction, and physical and chemical analysis; these uses do not include theintemal or extemal administration of radioactive material or radiation to humanbeings (except small gamma sources used to mark images produced as authorizedby 10 CFR 35.200).

H. Radiation shield and/or counterweight.

I. Reserved

. . _ - . .

_ _ _ _ _ _ _ _

.

O O.

Item 5. Part II. Research and Development, and Incidental Uses..

a. Isotope (s) b. Chemicaland/or c. MaximumPhysical Form Amount

J. Any bypmduct materials, but Any form 3 curies perisotope;excluding I-129 and alpha emitters 30 curies combined

total of allisotopes

K. Mo-99 and/or Tc-99m Any form 10 curies

L. Any byproduct materials Any fami 0.1 curie per isotope;0.5 curie combinedtotal of allisotopes

M. Any soume materials Any form 0.001 curie combinedtotal of allisotopes

,

N. Plutonium (mixed Pu isotopes) Sealed source 5 curies.

Item 6. Part II. Research and Development, and Incidental Uses.1

J.through N.: Research and development as defined in 10 CFR 30.4, student instruction,instrument calibration, 3hysical and chemical analysis, and animal studies;these uses do not incluc e the intemal or external administration of radioactive

j material or radiation to human beings.

,

; Item 5. Parts I and II. Medical Use, Research and Development, and Incidental Uses: Addendum4

A. through N.: In addition to the limitations above, all unsealed byproduct material ofhalf-life greater than 120 days will be limited to an "R" value of 3,000 perisotope, and an "R" value of 10,000 combined total of all isotopes, with"R" value defined as in 10 CFR 30.35. This limitation will be ensundthrough a quarterly inventory of all current isotope possessionauthorizations approved by the Radiation Safety Committee.

. _ _ . . _ _ __ _ _ _ _ . _ _ _ .. -

:1

-

9 o..

|

DEC 2 81993

i

|

License Number: 08-00216-22Docket Number: 30-09049Control Number: 116551

George Washington UniversityA'ITN: Allan G. Wasserman, M.D. ;

Chairman, Radiation Safety Committee )2300 Eye Street, N.W., Room B-32 |

| Washington, DC, 20037!

Dear Dr. Wasserman:

Subject: Financial Assurance

This is in response to your letter dated November 2,1993 to modify your possession limits ;

to set the maximum possession limits for License No. 08-00216-22 to the level that requires I

certification for financial assurance in the amount of $150,000. The following is an i

'

| acceptable method of achieving this possession limit:

l. For Items J, L, Q and R in your letter, you must specify a maximum activity per isotopeplus a total activity. An example of the wording for this would be "Not to exceed 20milheuries per isotope,20 curies total." Note that according to 10 CFR 30.32(i)(1) andthe proposed possession limits for Iodine-131, your license would require that youprovide an " Emergency Plan for Responding to a Release" for quantities greater than j

! those listed in 10 CFR 30.72, Schedule C. Please reduce the quantity of licensedl

material or submit an Emergency Plan.

2. A. License Conditions 6, 7, and 8 for Items M, N, O and P of your letter will bewritten as follows:

|

| 6. Any byproduct material with Atomic 7. Any 8. See Condition 12'

Numbers 1 through 83 and with half "

lives greater than 120 days,

Condition 12 will read: |i

12. If only one radionuclide with a half life greater than 120 days is possessed, thepossession limit is 10,000 times the quantity specified for that radionuclide in

OFFICIAL RECORD COPY - C:\ DOC \DECOMM\GWU - 12/27/93 ,

AIL 10

|

- .. ..

'

O O |'

,

George Washington University -2- |

IAppendix C to 10 CFR 20. If two or more radionuclides with half lives greaterIthan 120 days are possessed, the possession limit is determined as follows: For

each radionuclide, determine the ratio of the quantity possessed to 10,000 times|the applicable quantity specified in Appendix C to 10 CFR 20, for that

radionuclide. The sum of the ratios for all radionuclides with halflives greaterthan 120 days possessed under the license shall not exceed unity,

i

Please confirm that this is acceptable.

I

B. Please describe how you will manage your inventory of radionuclides to ensurethat you will not exceed the possession limits as stated in your license.

We will continue our review upon receipt of this information. Please reply in duplicate tomy attention at the Region I office and refer to Mail Control No. 116551. If you have anyquestions regarding this letter, please call David Everhart at (215) 337-6936.

Since your license requires financial assurance, we request that you submit your response tothis letter within 30 calendar days from the date of this letter.

Sincerely,

Original Signed By:Mohamed M. Shanbaky

Mohamed M. Shanbaky, ChiefResearch and Development SectionDivision of Radiation Safety

and Safeguards

bec:M. Shanbaky, RID. Everhart, RI

I

DRSS: DRSS:RIEverha S

12/$/93 12/[93 |

l,

OFFICIAL RECORD COPY - C:\ DOC \DECOMM\GWU - 12/27/93 )

:

|

. - . .

. . .

| ,.occ sa sa agrionsarcivovu eOea:22 en 2e2 s84 '- '

mu. '

The copy g_ t.

: eorge.S 11n3 ton! '

n1Ver$1tyWAS HING TON DC''

MEDICAL ONWR

RADIATloN $AFF.TY OFFICE

License No. 08-00216-23Docket No. 030-09049Control No. 111230

November 2,1993

John D. Kinneman, ChiefResearch & Development and Decommissioning SectionDivision of Radiation Safety and SafeguardsU.S. Nuclear Regulatory CommissionRegion 1475 Allendale Road

| King of Prussia, Pennsylvania 19406-1415|

'

| Dear Mr. Kinneman: *

| Pursuant to your letter of September 17,1993, and subsequent telephone conversations, the enclosed! additional information is formatted as a complete renewal application, for license mtmber 08-00216-22,

replacing all previous applications and license commitments m their entirety. Plea..; note especially theQuality Management Policy attached, which replaces the quality management program submitted inJanuary,1992, in its entirety.

| If you have any questions, please call me at 202-994 3149. ;

Sincerely,

4 yvd.F x

Terry 96hnsonRadiation Safety Officer

ii

TAJ/gjh (10B1cticenne93.2 Memo) ;

cc: John C. LaRosa, M.D.Dean for Research, GWU

,

enc 1. ||(,f,$~jCWICML EECORD UDPY #4 tu s na ein(esnon Evr STnET. N.W. Room Ba2 * WinN(; ton, DC 2mn e g<a3 99,2mn

_. - . . ._ _ ._ __

- _ -- .- .. _ ._ . . . .- ___ _

.

ATIDH SAFETY GWU 202 994 E Page 2.DEC 13 '93 03:32 PM PV.

.

=mc noau sia v s. MvCLtAn ateutAtomv Commissionme Aremovtp av eMe*0 CFR JD 7T,13. 3164 41241x wo APPLICATION FOR MATERIAL LICENSE s e*** s men

i

- 1INSTRUCTIONS: $t t THE AP*mOPNIATI LIGEN$5 APPUCAfl0N Gut 0E KQR OLTAILtO INSTRUCTIONS FOR CQMPL ATING APPLICATtQN, 3END TWC CQFIE S |

08 TMt ENTimt toMPLETto APPt.iCATION TQ THC NRC CP81CE SPf clPitD GELOw.

AppuCAfl0N$ Pd4 OISTA,0VTiO4 of (RiMPT PRODUCTS FILE APPLICATIONS WFTH. tp You A At LocATgp iN

u s NuCLlaa atGULATCAv COMMifsl0N l(Ll40f t. IN0i ANA. toWA MecMIC A8( MINNf 90T A. hil&oupi,0Mio,0 AOswiSION OF iNDW57a: AL ANQ W50icAL NuCLf A4 SAFETY, NW$5 FHSCON11N, SEND APPgjgAT)QN$ TQiWASeslNCTON. OC 30555

SLL Q1HER P(A$QN4 fil4 APP (iCATIONS A5 FULLOWS,IF YOU ARE D $ NUCLEAM REQU,LATQny COMw331QN, REGION til,

|M Aff mi AL$ LectNs NQ ${CTIONLOCATED IN. 799 A00atvt69 ngAD

<

|'CONNECTICUT, OtLAW art. DistniCT 08 COLUMela. MAINE. MARYLAND

MASSACHyltff $ NfW HAMP1MIAf, NfW JERSET, NrW YORE. Pf Nm8YLVANIA, A a KA NSAS. COLDAA00,10AMO. stANaAA. LoutSt A NA. ancas t ANA. Nf en AAK A.DIODE ISLANO, CA wf RMONT. af h6 APPuCA TIONS TO: NEW Mt a cco, Non f H nAst0TA. Oct LAHOMA. SOUTH DAR OT A. M M W AM.

u t NUCLI An at4ULATUav COMw$$ ION REGION I '

NUCLEA# MavEmiALS $ArgTV $4CT10N B U $ NUCLE A4 AtGU(ATORY COMU'8000*8. REGION IV47% AU.ENDALE ACA0 m Af amiAL mAciaTigN emotacitoN stCTIONRING 08 PAU1$!A, 'A ,19000 gig av AN DLA2A OAivt,3UITE 1000

at AS AM A. FloalO A. GIOaCI A. Kf NTUCKW Mtf,411%rrt. NomT)6 CA ACON A. * jPva nTo adCO. 9QU1H CARQUNA. TENNf S$f f, VIAG NsA, VimQiN iluMC5. OR AL Atra, A RtFOerA, Call'ORNI A NAFIAll. Ntva04, OA f 0016. gr45NINGTON.Wt37 winglNIA, $tNQ APPVGATIQMS 10: AND u 3. f tRafTORtts AND PO$$998 TONS IN TH8 PACJPIC, SSNO APPLICATIO888

U.$ tiUCLEAR lif gut.ATC AF COMMi$$>CN, R$GiON leNyctAR MaTleiALS SAFFTY SECTION y g. NUCL&A4 WEQULAfony COMMIStiON, REGION VIci asAmirTT A $ 78EET,5u1712900 NUCLEAR MAT (RIAL $ SAffTV SECTIQ'sATLANTA, GA M3 lace MAmeA LAME. Sutrt 210

WALNUT CNERK, CA Saeet .

l*

pessoaig g ocATgo sui AcaggugkT STATgg ggko apet scaYteN1 TD tuf u t efuc(tan aggyLATony consasiggION QssLY iP THGT WISH TO POAIfilt ANO L81f LICINSED MATERIAL 1

gas gTAf ts $V9 JECT TO V 3. NUCLt Aa aggvLAY0af Conewssicq JuntsoiCTioN.

vnses is Aa ApeL< CAT 6cN FOR /CAega appropwe es**'t 3. 'e AME AND MAlyNQ AQQRES$ of AMuCANT l/servdele Corefs

A. Nea uct%se The George' Washington University_

e A eNeotNTTo uC N$i ww ** - Office of Research]lpriorsubmittalsintheirentirety.e a:No. A 0s uev.ss Nuwst. 08-00216-22: replacing 2300 I Street, N.W. ,- Suite 708at Wa-hineton. DC 20037_

,

!i ACoain, o . e e uCe.sa s - A 1. 4 6 u .. . tp o. .essias

| T icensed material shall be used only"at t The George Washington University, bounded by.

annsylvania Ave., NW, r St., NW, 19th St. , NW, and 25th St. , NW, and other buildings in| the immediate arca, in Washington, DC, whose main address is 2121 1 St., NW. Washington,

DC 20052; and The George Washington University, 20101 Academic Way, Ashburn, VA 22011.1

1a u 0, ,s.. son ro ei ec T aC is ..w T is A..vCAT.oNgiaks -o- Num.

h rv A,_ Johnson 202-994-2630sygwiT ertaes 3 TwoouG= * * CN da e ti Porta T=a not 4No SC q cs iNsCava tion To ss F*igvicto 1$ 0tSCAittD iN TMt UC1N$$ AP*uCATiosg Gui0t.

t 4A0icaC*:vt WAf taiaga 8 e-es sae =ese aw%==. O ea*Nes s Nei savoi.e. 'o"a eae s mewswai s** wet 6 PV88 cst;$l FOR WHICM LICEN$t0 Matl41 AL %e'kk gl VSED, j

aena o tir ewe, e et eaven e.*e

|

[ma',N NYN NgDg$."C's s taAw,NG oo4 |N0tvicuaks WonstNo iN on entoutNTiNG AtsTAictic a nt As.I 0" # '' " 8 ' " T " '" "^*'"O '"'O

- _

v s 40 utets AND th *w(NT 9.5 = N/A. " " ' C ' ' T 'C ' *^ ' " Y '" 00 "'"~^

a . , n wC3,sts essa une tu vo ac ene ser.e vo orgaucuNT*i masts waNacawga.T -

_

Pf f CAftGORv 7g pNCLGEt3 $ N/A.3 Cians Catc4 %.e an ce-e. ewe e, we.wn Tus Ae*6, CANT uNotasT4Nos T> A T Au s r A v evtNT5 AN D Atpag gg NT Af @N5 MaQE tN THi3 AP*LICa ttCN AP G

giNaiNJ *c% Tut 48*vCANt

ve g 4pe. C A N* AN ANv 08 8 rcial t e tt,? INS twis canfip,CATtcN cN eg eats $s Twt AP'LtCANT, Nawso iN ITIu t, fERTiry TH AT t>tt ApuCAfl0N ilpag **MED IN CONE towTv w'Ta ?iTLE to Cott 0F stCanal,enoutAT 0NS,pasT130 32 33. Ja,36. ANO no AND THAT ALL INFORMATiON CONTAINED Mt pflN.is inyt ANo C04mECT to Tat St37 0p Tatis nNonitgGa ANc glut 7

e amNiNG is u s C SECSON 401 aC"05 JUNI 26 isas 63 TT AT. fas wAn es it a CmMiN At OrpEN58 TO WAn.E A WikkpVLLY P ALSt STAf tutNT on pi'WElsNT ATICN?C ANv Of f aatuf NT G4 AGINCV 08 T=t WNiTED ST Avts As to ANY MATTE P wit *N IT3 statsceCTiou

$sGN 'yE L .C le T a'Fv* OF F'C E R TVft0,paWTt3 NAUT fjfd QAT6

Roger E. Meyer, M.D. Vice President for Medical/ g - (h b Affairs and Executive Dean

FOR NRC Utt ONLYest gs ste #45 LtG sit CA'tG0pv CowytNr)

acum? a t *tivt0 CHECK NUM949

ApeaQvip EY DAT$

EstiuA?to aunbtN pf * at$80N$t 70 CCv%v wiTw TwlINeonwAfiCN COLLtcTiON DEcutsT. 7.s ums.NaC PCMu 312 E945FOMWA AD CCWWENT4 REGAmDINQ SYMCtN fiTiM ATE TO Twf Af CORCS ANQ REPORTS MANAGIMf MT SA ANCH (P A301.U 8 NuCtg anD E GULatomv CouMistION W ASM'NCON DC 70Ssl ANO T01NE 078sCE Ds sNronMATnDN ANo m8GukATORY AF8 ALWS.cF 8sCu s as 41'.8ssibt essn er ifV.87 dkatwibs1 TAN Pr iosms j

1

I

. ._

SAFETY GWU 202 994 C') Pogs 3F8'.fl0HDEC 13 '93 03:33 PMa d G

,

|.

1'

Items 5 and 6. Radioactive material to be possessed, and purposes for which it will be used.

Item 5. Part I. Medical Use, and Incidental Uses,

a. Isotope (s) b. Chemical and/or c. Maximtunl'hysical Form Amount

A. All byproduct materials All forms usable As neededidentified in 10 CFR 35.100 under 10 CFR 35.100

B. Allbyproduct materials All forms usable As neededidentified in 10 CFR 35.200 under 10 CFR 35.200

C. All byproduct materials All fonns usable As neededidentified in 10 CFR 35.300 under 10 CFR 35.300

D. All byproduct materials All fonns usable 3 curiesidendfied in 10 CFR 35.400 under 10 CFR 35.400 in total

E. All byproduct materials All sealed sources usable 3 curiesidenufied in 10 CFR 35.500 under 10 CFR 35.500 in total

F. All byproduct materials Scaled, plated or 0.2 curiewith Atomic Numbers 1 - 83 plastic sources, floods, in total

and calibation standards

G. Any byproduct material Scaled or plated sources 0.05 curiein total

11. Uranium, depleted in U 235 Cadmium-plated metal 300 kg

1.: Reserved

item 6. Part I. Medical Use, and Incidental Uses.

A. All uptake, dilution or excretion procedures approved in 10 CFR 35.100.

B. All imaging or localization procedures approved in 10 CFR 35.200. i

C. All radiopharmaceutical therapy procedures approved in 10 CFR 35.300.

D. All brachytherapy procedures approved in 10 CFR 35.400.

E. Medical use of sealed sources included in 10 CFR 35.500,in compatible devicesregistered pursuant to 10 CFR 30.32(g),

i

F. & G. Calibration, quality assurance, image marking, instrument checking, student |instmetion, and physical and chemical analysts; these uses do not include theinternal or external administration of radioactive material or radiation to human ,

beings (except small gamma sources used to mark images produced as authorized !|by 10 CFR 35.200).

H. Radiation shield and/or counterweight.

I.: Reserved

.

- acc 2 3 93 es:34 en t arron sarcry ovu zez ss4 eaa. 4

.

Item 5. Patt II. Research and Development, and Incidental Uses.

a. Isotope (s) b. Chemicaland/or c. Maximum- Physical Form Amount

J. Any byproduct materials Any Form 20 cudes combinedwith Atomic Numbers 1 - 83, totalof allisotopeswith half-life less than 120 days

K. Mo 99 and/or Tc-99m Any Form 10 curies

L. Any byproduct matedals Any Form 0.005 curie combinedwith Atomic Numbers 84 - 103, totalof allisotopeswith half-life less than 120 days

M Any byproduct materials Any Form 3 cudes combinedfor which the activity listedin totalof allisotopes10 CFR 20, Appendix C,is 1,000 pCi

N. Any bypteduct materials Any Form 0.1 curie combinedfor which the activitylistedin total of allisotopes10 CFR 20, Appendix C,is 100 Ci

O. Any byproduct materials Any Form 0.01 curie combinedfor which the activitylistedin totalof allisotopes10 CFR 20, Appendix C,is 10 Ci

P. Any byproduct materials Any Form 0.005 curie combinedfor which the activity listed in total of allisotopes

- 10 CFR 20, Appendix C,is 1 Cii

1

Q, Any byproduct materials Sealed sources, 5 curies combined iwith Atomic Numbers 1 - 83 plated sources, totalof allisotopes '

platinum-iridium wire,seeds, plastic floods, ;

rods and buttons, and 1

calibration standards|

R. Any byproduct materials (e.g., Scaled sources, 1 curie combinedPo-210, Am-241, Cm-244, & plated sources totalof allisotopesCf-252)

S. Thorium-228 and Thorium-230 Plated sources 0.001 curie

T. Plutonium (mixed Pu isotopes in Be-9) Scaled source 5 curies

|!

Item 6. Part II. Research and Development, and incidental Uses.

J, through T.: Research and development as def'med in 10 CFR 30.4, student instmetion,instrument calibration, physical and chemical analysis, and animal studies;these uses do not include the internal or extemal administration of radioactivematerial or radiation to human beings.

|

|

._ _ _ _ _

. ..

O O* *

SEP 1.719931

License No. 08-00216-22Docket No. 030-09049Control No. I16551 ;

:

George Washington UniversityATTN: Allan G. Wasserman, M.D.

Chairman, Radiation Safety Committee2300 Eye Street, N.W., Room B-32Washington, D.C. 20037

Dear Dr. Wasserman:

Subject: Financial Assurance

This documents a telephone conversation on July 28,1993 between David Everhart of ouroffice and Terry Johnson of your staff. During the telephone conversation, the followingitems were discussed:

1. In a letter dated July 26,1990 from Brian L. Miller, you state that you wish to havefinancial assurance contingent upon your actual possession of licensed materials ratherthan the possession limits stated in your license. 10 CFR 30.35, however, requiresthat financial assurance be based on authorized possession limits. Your request tobase financial assurance on actual possession cannot be approved.

2. One method of limiting the financial assurance required is to add to Item 6.A. of your ;

license "with half-lives of less than 120 days" and to list the specific radioactivematerials you wish to possess with a half-life of greater that 120 days as separate ;

items. The total of these materials must be less than that requiring financialassurance.

3. Another method of reducing the amount of financial assurance required is to requestthat your license be converted to a modified Type B license of broad scope. Theamount of financial assurance required with this modified Type B license is$750,000.00. A Decommissioning Funding Plan and actual cost estimate are notrequired. The modified license is implemented with the following condition:

.

OFFICIAL RECORD COPY - S:\NMSB\DEF\GWUTEL. CON - 09/16/931

ML 10 l

l- .- __. -

'

.-. - . . . .

_ .- -

.. .

.

O O i' "

George Washington University . -2-

1a. If only one radionuclide is possessed,- the possession limit is the quantity '

specified for that radionuclide in 10 CFR 33.100, Schedule A, Column I. Iftwo or more radionuclides are possessed, the possession limi? is determined as :follows: For each radionuclide, determine the ratio of the quantity possessed .I

to the_ applicable quantity spec _ified in 10 CFR 33.100, Schedule A, Column I,for that radionuclide. The sum of the ratios for all radionuclides possessedunder the license shall not exceed unity.

i

ib. Notwithstanding subitem A. of this Condition, above, and 10 CFR 33.100, 1

Schedule A, Column I, tlw .pplicable quantities in Condition 12.A. for the lfollowing radionuclides ac reduced to:

Carbon 14 10 curiesKrypton 85 10 curies |

Iodine 129 10 millicuries !

!

Any byproduct materialothe: than alpha emittingbyproduct material not

i

listed in 10 CFR 33.100, ;

Schedule A. 10 millicuries i

Financial assurance is required for your license as it is currently written. Therefore, we |request that you respond with a Decommissioning Funding Plan including an actual cost -)estimate and a financial assurance mechanism in the amount of the estimate and/or a request '

; to amend your. license within 30 days of the date of this letter. The enclosed Regulatory| Guide 3.66 may be helpfulin preparing your response. If you decide to prepare a cost| estimate, the enclosed NUREG\CR-1754 may be helpful. If you have any questions, please '

call Mr. Everhart at (215) 337-6936. When you respond, please refer to ControlNo.116551.

|

|

| Sincerely,

!| Onginal Sed 91:| John D. Kinnemaii John D. Kinneman, Chief

Research & Development andDecommissioning Section

Division of Radiation Safetyand Safeguards

I i

i '

OFFICIAL RECORD COPY - S:\NMSB\DEF\GWUTEL. CON - 09/16/93 I

i

_ _ _ _ _ _ _ _ _ _ _ _ . . _ __ . . . . _ . . . _ . ..,_.. . , . . ......_._... , _ ._._._

-

O O. .

:\

1|

,

George Washington University -3- )| \

!

Enclosures:;

1. Regulatory Guide 3.662. NURl;G\CR-1754 l

3. NUREG\CR-1754, Addendum 1

cc:Terry Johnson, Radiatiot jafety Officer

l1

bec:

| J. Kinneman, RI

!

|

|

1

I

l|

|t

|

Ii

I

I

"/DRSS: :RIEverhart/gc mneman

9/|b/93 9//l//93

OFFICIAL RECORD COPY - S:\NMSB\DEF\GWUTEL. CON - 09/16/93

, . .. - . . - . . .

. .

TELEPHONECONVERSAhNLOG hy 28,DATE: 1993PERSON CALLED: ORdANIZATION: TELEPHONE NUMBER:

Terry Johnson George Washington University (202) 994-2630LICENSE NUMBER: DOCKET NUMBER: MAIL CONTROL NUMBER:

08-00216-22 30-09049 116551* |;; .

lPERSON CAWNG: David B. Everhart (215) 337-6936

USNRC Region I FAX Numbersi 475 Allendale Road (215) 337-5269 or

King of Prussia, PA 19406 (215) 337-5234sUa:E m Decommissioning / Financial Assurance

SUMMARY:

; Discussed D/FA options|

! 1. Modified Broad Scope Type "B"

| 2. Limit Condition 6.A to material with a half life of less than 120 days

3. Condition limiting " Sum of Fractions" such that level of F/A desired isnot exceeded. eg. $150,000, $750,000 or DFP requirement.

.

Will review options and respond within 30 days.|

|1

!

l

l

!

|

|

||

|

ACTION REQUIREDITAKEN: Await hard copy response

!

SIGNATURE: DATE:

OFFICIAL flECORD COPY ML 10_ _

)*. .

,

o o-- -. .

93o- 090 97-

THE nasiation safery ortice

h m,,, /282/99*2630GEORGEWASHINGTONUNIVERSITYr

V MEDICAL CENTER g'' ' (|| OD]QWarwick BuiMing ||300 K Street, X W. I Washington. O c .'!Leg ___ M % .___.lS---- -- -.

o.5EE I5 b fkC -

IITCdAmount..'8 N0 - E a M - p v IA/ '1

'

Fce Category - __"]- --

7 [L'jf 1Type of Fee ___ L120dg

f s-July 26,1990Date Check Roc'd._$l $1E t-

''

<MkU.S. Nuclear Regulatory Commission osto completed _ Rbj /9 B- 9Materials License Division sys _ Jag _ _ _ _ _ _ - c-

M4~ ::475 Allendale Road v

King of Prussia, Pennsylvania 19406 tRE: Broad Scope License # 08-00216-22

Sir:

In examining the requirements of 10 CFR 530.35, the George Washington University has notedthat although the actual possession of Radioactive Material by the University is relatively small,the Broad Scope License held by the University would require a large Financial Assurance. Asthe intent of the Financial Assurance Regulations is to insum that licensees have adequate funds todecommission their existing facilities, the possession of byproduct material would appear to bethe most valid test of the quantity of financial assurance required. Therefore, we would like toamend our Broad Scope License (# 08-00216-22) as follows to reflect the maintenance ofFinancial Assurance based on the actual possession of Radioactive Material.

"The George Washington University will verify on at least a quarterly basis that thepossession of radioactive material has not exceeded such quantities that would cause the'R' value as defined in 10 CFR 530.35.(a), to exceed 104 in any two calendar quartersduring the four previous calendar quaners. Should the possession of radioactive materialsreach quantities which would cause the 'R' value to exceed 108 as stated above, the George

4Washington University will submit Financial Assurance based on an 'R' value of 10 thru510 within six (6) Months.

4If the University has not exceeded the 'R' value of 10 in two of the past 4 calendarquarters, the University will maintain Financial Assurance based on an 'R' value of 103thru 104."

,.

- - .a.Should you have any questions, please centact me at (202) 994-2630, Monday through Friday,8:00 A.M. to 5:00 P.M. !

'

_

- .

.. u ._% '

Sincerely, _ _._ _ _ _ _

[2 (Brian L. Miller i

~

];'

T I~^'S Hb~'~Radiation Safety Officer ~ LC- b t

m3 J

BLM/gjh (12D1a) {{ hh ] [ |[iy~. _ _ _ -,.,

+; p D- . 3gggg5'

OFFICIAL RECORD COPY ML 10 MAY 0 41992~

lt

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ .-

,

. * e.

D*' ,

(a -s.

.

: ( c ^. ' Lc"S USE),

. e, c q ,s . . . . . n u. g,.... L v e.,,.. . .o . e. w

3 r. ..n .. e n..e . .. _. .. .. ...._..

L ! C " '; S 7 F E F. 9 A *J A ', E 't r *J T '?ANCW, '01 : P R O M A *1 CODE: 02110.

* tj D : ST AT US C03E: 2.

e ? ~ 3 I J 'i '. L L I ! E 'J 3 I N G SECTION: : "E: CATI ~0~Y: 75-

e_ x p . m .a. T e . 19971?'^.. _. -

c:r C o u M c N T '> :4 - o ' - _._.. ...._ .___ ____

g r C 's .'1 5 7N A ~3 .> U R 25^<n. y#s.

l............................................................................

L.-_,., : c ;. .~ pcI i 4 . t .e .Iv..... a ! *L.s e > i

, . n .1- o.

1. , - u . r . . I n .J . e sI - e.. v .,,.- 4. <,iu.. naf. PLICA 1T/ LICE 15 2: G E O R ", ? WA<4INGTO'I U'JIV. MEDICAL C T O.

? E C EI Vi ? DAT?: ??O5C4-nr.y:T o. t -7 T P., ^ ) '' '+ '<s ..

CnNT?CL NC.: 116551L T n .. _s =. ..e.. ., ~ . . . , , 1 e. ,. va... . . . ....

r.. r n. , T Y p r_ . 3 .a. r. tJ n. u n . e. . . . . .i

2. ~EF ATTACHED"u-.,y...

'- .. ____

un .:. r y. .o.. __ __. ._

m.

t. . v . p. u. e sJ 1 -3--

+*~,s . ___ . _ f.. f. __ ._*__ .____,2 .

^ ATE - _ _ _ . . f" .7 _.__._.._._fL . r .o ..: :.- -

,

u.>.......47 , , *. ,J e. y (r.ar.C<.. ''H 1 A* . i - T. r) tl - O '. - +- 't' - - c. 3 ..

'.au. .ct - . e u. - 4 .a c +-

.-

. . . 3 ..

\ ..

, _

1. ~ ~. c P ~T ''''Y 3".<'- ""^U".T.""~ - -

___........_...__..__..__.. ...r t..._ _ -

c%.. . W.. W . - ----.m. . .

3 c. ., : r. .; w v. c r. r oc,. taatic.- cy 9.y er n q c c. . g e. r.. ,. p a :. .v : . < n s . ~ ..

N. g r . m a ;,, 74 a a . ........_ ..._- , , .i:4.L' .r __...____ ...

e r .J < - ..._......._-_,-> --

1 ^iac2-,-- ...___... __ ..___.._ .. _.._ ..._

___....._-__..___._...._-___._.._. ,

__..._....___fJ. )e n...3>x >. ~ __ _____ __

Fair.._-_ ... . ._. ./ _c ~y_'__...__.-- - 4.

]

_. _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ .__.